| Literature DB >> 28675773 |
Philipp Schattling1, Essi Taipaleenmäki1, Yan Zhang1, Brigitte Städler1.
Abstract
Although oral is the preferred route of administration of pharmaceutical formulations, the long-standing challenge for medically active compounds to efficiently cross the mucus layer barrier limits its wider applicability. Efforts in nanomedicine to overcome this hurdle consider mucoadhesive and mucopenetrating drug carriers by selectively designing (macromolecular) building blocks. This review highlights and critically discusses recent strategies developed in this context including poly(ethylene glycol)-based modifications, cationic and thiolated polymers, as well as particles with high charge density, zeta-potential shifting ability, or mucolytic properties. The latest advances in ex vivo test platforms are also reviewed.Entities:
Keywords: gut-on-chip; mucoadhesion; mucopenetration; polymers
Mesh:
Substances:
Year: 2017 PMID: 28675773 DOI: 10.1002/mabi.201700060
Source DB: PubMed Journal: Macromol Biosci ISSN: 1616-5187 Impact factor: 4.979